ASE Joins Cardiovascular Coalition Comments on OMB Uniform Guidance Proposed Rule

On July 13, ASE joined ACC, ASNC, SCAI, and SCCT in submitting joint comments urging OMB to withdraw the proposed Uniform Guidance rule. While acknowledging the Administration’s goals of transparency and efficiency, the Societies warn that the rule risks politicizing scientific decision making by allowing administrative personnel to override expert peer review, that expanded “for convenience” termination authority would waste federal investment in long-term clinical trials and registries, that restrictions on international collaboration would undermine U.S. leadership in multinational research, that new compliance requirements would add administrative burden, and that limits on publication and subscription costs would restrict the dissemination essential to translating research into practice. The Societies request withdrawal and future stakeholder engagement.

Joining this letter aligns ASE with the broader cardiovascular community on an issue with substantial consequences for the field. Cardiovascular disease remains the leading cause of death, and the imaging research ASE members conduct depends on stable multi-year funding, expert-driven review of technically complex applications, international collaboration, and viable publication pathways. A unified voice across the cardiac societies strengthens the case that these provisions would weaken, rather than improve, the return on federal research investment.